Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Core One Labs Inc
Bullboard Posts
User Avatar Image
(2)
•••
Post by Lump36on Aug 18, 2019 1:09pm
52 Views
Post# 30040875

Facebook/Bullboard=talk not action

Facebook/Bullboard=talk not actionEach day spent not complaining to those who can delay or stop this R/S is another day wasted!
Don’t know if the exchange can do anything but complaining on FB/SH certainly doesn’t do anything!
Tomorrow is Monday please flood CSE with complaints about this issue or the other contact previously provided! 

For General Inquiries Contact: info@thecse.com
For Listing Inquiries Contact: listings@thecse.com
For Trading Inquiries Contact: trading@thecse.com

CANADIAN SECURITIES EXCHANGE
CNSX Markets Inc.

 

Address 100 King Street West, Suite 7210
Toronto, Ontario, M5X 1E1
Phone 416-572-2000
Fax 416-572-4160

VANCOUVER OFFICE

 

Mailing Address 100 - 535 Thurlow Street, Office 1122
Vancouver, British Columbia, V6E 3L2
Phone 604-331-1213
Fax 604-687-1188
 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities